Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celera Genomics (CRA) -- Ignore unavailable to you. Want to Upgrade?

To: gao seng who wrote (526)	6/29/2000 12:32:00 AM
From: Susan G	Respond to of 746

Not sure how many so far, but three big ones in the past 6 weeks or so. I don't have time to research it right now. I think we will be seeing quite a few soon, now that the "big news" is out.

To: gao seng who wrote (526)	6/30/2000 1:41:02 PM
From: allen menglin chen	Read Replies (1) \| Respond to of 746

Steve Newby, Genomicsfund.com Author Dwivedi Report Source Steve Newby (Added 6/30/2000 6:12:54 AM)Categories: Sector Reports, Stock Picks Email link to this Article Steve Newby, Genomicsfund.com: CRA Steve Newby, Founder of Genomicsfund.com, comments on the sector: -Fund is pure genomic play; tremendous potential in this industry and one of its kind fund -Trying to find the very best names and top tier stocks in the genomics area, particularly among: genomic delivery tech; tools; pharma-genomics; and, database -Beginning of the genomics age -Stock picks: CRA: map of the human genome shows the competitive ability of scientists at CRA; annotation of genomic code to follow; co. signing up customers fast, with three new deals this week; moving ahead towards profitability netcognizance.com